Covered recipient · General Payments record
APURVA A MOTIVALA
Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology
General Payments · PY2018–2024
$18,433.79
- Reported across 155 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,625.02 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $458.56 | 7 |
| ABIOMED | $419.74 | 11 |
| Medtronic, Inc. | $343.83 | 10 |
| CVRx Inc. | $149.35 | 1 |
| Amgen Inc. | $146.61 | 1 |
| Abbott Laboratories | $87.82 | 4 |
| CORDIS US CORP. | $19.11 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.07 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125313526 | CMS |
| Abbott Laboratories | $18.05 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125313528 | CMS |
| Abbott Laboratories | $19.82 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125313530 | CMS |
| Abbott Laboratories | $25.88 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125313532 | CMS |
| ABIOMED | $19.80 | 01/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142210666 | CMS |
| ABIOMED | $157.14 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142210678 | CMS |
| ABIOMED | $20.53 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142210674 | CMS |
| ABIOMED | $19.70 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142210692 | CMS |
| ABIOMED | $19.86 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142210694 | CMS |
| ABIOMED | $2.55 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142210662 | CMS |
| ABIOMED | $97.54 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142210740 | CMS |
| ABIOMED | $8.30 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142210742 | CMS |
| ABIOMED | $23.57 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142210760 | CMS |
| ABIOMED | $24.11 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142210762 | CMS |
| ABIOMED | $26.64 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142210770 | CMS |
| Amgen Inc. | $146.61 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111656764 | CMS |
| Boston Scientific Corporation | $10.96 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092280602 | CMS |
| Boston Scientific Corporation | $135.78 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092280604 | CMS |
| Boston Scientific Corporation | $4.82 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092280596 | CMS |
| Boston Scientific Corporation | $150.00 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092280608 | CMS |
| Boston Scientific Corporation | $5.69 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092280598 | CMS |
| Boston Scientific Corporation | $6.41 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092280600 | CMS |
| Boston Scientific Corporation | $144.90 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092280606 | CMS |
| CORDIS US CORP. | $19.11 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145406009 | CMS |
| CVRx, Inc. | $149.35 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133237425 | CMS |
| Medtronic, Inc. | $194.91 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119524210 | CMS |
| Medtronic, Inc. | $8.00 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119524212 | CMS |
| Medtronic, Inc. | $2.45 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119524214 | CMS |
| Medtronic, Inc. | $7.75 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119524216 | CMS |
| Medtronic, Inc. | $13.27 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119524218 | CMS |
| Medtronic, Inc. | $13.14 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119524220 | CMS |
| Medtronic, Inc. | $43.20 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119524222 | CMS |
| Medtronic, Inc. | $23.72 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119524224 | CMS |
| Medtronic, Inc. | $28.22 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119524226 | CMS |
| Medtronic, Inc. | $9.17 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119524228 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.